Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cell Transplantation is a pharmaceutical drug with 12 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
2
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Retrospective Results of Micronized Adipose Tissue in Patients With Interstitial Cystitis
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury
Clinical Trials (12)
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Retrospective Results of Micronized Adipose Tissue in Patients With Interstitial Cystitis
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury
Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines
Intra-Osseous Co-Transplant of UCB and hMSC
Comparative Study of Strategies for Management of Duchenne Myopathy (DM)
Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study
Stem Cell Transplantation in Cirrhotic Patients
Bone Marrow Derived Stem Cell Transplantation in T2DM
Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12